Welcome to our dedicated page for Enovix Corporation SEC filings (Ticker: ENVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Enovix鈥檚 SEC disclosures can feel like navigating a lab manual. The company鈥檚 silicon-lithium battery platform, BreakFlow safety layer, and orthogonal cell architecture introduce technical details that stretch a single 10-K well past 250 pages. If you are searching for 鈥淓novix SEC filings explained simply鈥� or wondering where the capital for its new manufacturing lines is coming from, you are not alone.
Stock Titan bridges that gap. Our AI-powered summaries extract the numbers and narratives that matter鈥攆rom Form 4 insider transactions in real time to each Enovix quarterly earnings report 10-Q filing. Type a natural question such as 鈥渦nderstanding Enovix SEC documents with AI鈥� and instantly see R&D spend trends, factory yield updates, and customer concentration data. We monitor every Enovix 8-K material events explained notice, flagging supply-chain shifts the moment they hit EDGAR, and track Enovix executive stock transactions Form 4 so you can spot buying or selling before the market digests it.
Whether you need an Enovix annual report 10-K simplified to grasp long-term production targets, an Enovix proxy statement executive compensation breakdown, or an Enovix earnings report filing analysis that highlights gross-margin progress, our platform delivers. You鈥檒l also find a concise timeline of Enovix insider trading Form 4 transactions, interactive charts comparing quarter-over-quarter CapEx, and alert tools for 鈥淓novix Form 4 insider transactions real-time.鈥� Save time, understand the technology risks, and make informed decisions鈥攚ithout diving into every footnote.
SEC filing: Form 4 for Enovix Corporation (ENVX).
On 08 Jul 2025, President & CEO Rajendra K. Talluri reported a disposition of 17,925 common shares (transaction code F) valued at $13.44 per share. The shares were withheld by the company to cover tax obligations arising from the vesting of restricted stock units (RSUs); no open-market sale occurred.
After the withholding, Talluri directly owns 2,399,871 ENVX shares, including 1,928,640 shares that will be issued upon future RSU settlement. No derivative transactions were reported.
The event is routine, reflects regulatory compliance, and does not materially alter insider ownership or signal a strategic change.
Enovix Corp. (ENVX) 鈥� Form 4 insider transaction report filed 07/08/2025
- Reporting person: Kristina Truong, Chief Accounting Officer.
- Transactions: Two Code 鈥淔鈥� dispositions (share withholding for tax on RSU vesting).
- 07/01/2025 鈥� 2,220 common shares withheld at $10.15.
- 07/05/2025 鈥� 637 common shares withheld at $11.39.
- Post-transaction ownership: 210,054 common shares, including 179,180 RSUs that remain outstanding.
- No open-market purchases or sales; activity is administrative to cover payroll tax obligations associated with restricted stock unit vesting.
The filing does not indicate any change in investment intent or strategic outlook; Truong continues to hold a substantial equity position.
Great Elm Capital Corp. (GECC) 鈥� Form 4 insider transaction: 10% owner Great Elm Strategic Partnership I, LLC reported two open-market sales of GECC common stock.
- 7 Jul 2025: Sold 11,852 shares at $10.95 per share.
- 8 Jul 2025: Sold 3,218 shares at $10.95 per share.
Total shares sold: 15,070, representing roughly 0.8 % of the holder鈥檚 previous 1.81 million-share position. Post-sale direct ownership stands at 1,798,365 shares. No derivative transactions were reported.
The filing signals a modest reduction by a large shareholder; the dollar value of the sales is approximately $165 k, limited in relation to the remaining stake.
Core & Main, Inc. (CNM) 鈥� Form 4 insider transaction
Executive Chair Stephen O. LeClair reported two option exercises and corresponding open-market sales.
- Option exercises: 80,028 shares on 07/03/2025 and 44,972 shares on 07/07/2025 at an exercise price of $20.81 per share.
- Sales: The same share counts were sold on the respective dates at weighted-average prices of $62.2681 and $61.9143 (price bands $62.10鈥�$62.47 and $61.63鈥�$62.28).
- Share disposition: Aggregate shares sold total 125,000. Following the transactions, LeClair directly owns 70,736 Class A shares and 135,877 vested options expiring 03/10/2032.
- Vesting schedule: The options vested in three equal tranches on 03/11/2023, 03/11/2024 and 03/11/2025.
The filing reflects routine exercise-and-sell activity by a senior insider at prices roughly three times the exercise cost, reducing鈥攂ut not eliminating鈥攈is equity exposure.
Enovix Corporation (ENVX) 鈥� Form 4 insider filing
President & CEO Rajendra K. Talluri reported an F-code transaction dated 1 July 2025, indicating shares were withheld to satisfy tax obligations arising from the vesting of restricted stock units (RSUs). A total of 15,539 common shares were withheld at an indicated price of $10.15 each. Following the transaction, Talluri鈥檚 reported beneficial ownership stands at 2,417,796 common shares, of which 1,962,556 are issuable upon future RSU settlement.
No open-market buying or selling occurred; the disposition does not reflect a strategic sale but an administrative tax-withholding event. Ownership remains substantial, suggesting continued management alignment with shareholders.
Globalink Investment Inc. (NASDAQ: GLLIU) filed an 8-K on 3 July 2025 announcing its 25th deadline extension for completing a de-SPAC transaction. The company deposited $0.15 per public share, or $10,890.15, into its trust account, pushing the business-combination deadline from 9 July 2025 to 9 August 2025.
This is the second of up to six one-month extensions allowed under the SPAC鈥檚 amended charter. The cost of each extension is borne by the sponsor and preserves the trust鈥檚 cash per share for investors. No target has yet been announced, leaving investors reliant on continued extensions or a potential liquidation if a deal is not secured by the final permitted date.
Key details
- Form type: 8-K, Item 2.03 (Direct Financial Obligation).
- Extension payment: $10,890.15 ($0.15 per share).
- New termination date: 9 Aug 2025.
- Total extensions since IPO (Dec 2021): 25 months.
- Exhibit 99.1: Press release describing the extension.
Investor take-away: The additional month preserves the SPAC option value but underscores management鈥檚 prolonged search for a target. Each successive short-term extension increases uncertainty over eventual deal quality and timing.
HeartCore Enterprises, Inc. (Nasdaq: HTCR) filed a Form 8-K dated 2 July 2025 to disclose that it has signed a consulting agreement with Cipher Core Co., Ltd. for its Go IPO advisory service, which helps Japanese companies prepare for U.S. stock-market listings. The disclosure is furnished under Item 7.01 (Regulation FD); therefore it is not subject to Section 18 liability and does not amend any prior financial statements.
No details were provided regarding contract size, duration, fees or performance milestones, and the registrant expressly states that the information should not be assumed material solely because it is being furnished. The only exhibit is the related press release (Exhibit 99.1). No other items, financial data, or pro-forma statements accompanied the filing.
For investors, the announcement signals continued demand for HeartCore鈥檚 fee-based Go IPO consulting offering, potentially diversifying revenue beyond the company鈥檚 core CX platform. However, the absence of quantitative metrics makes it impossible to gauge the magnitude of the opportunity or its near-term earnings contribution.
Enovix Corporation (ENVX) 鈥� Form 4 insider filing: Chief Legal Officer Arthi Chakravarthy reported an automatic share withholding related to the vesting of restricted stock units (RSUs) on 24 June 2025. The Form 4 lists 2,217 common shares withheld under transaction code 鈥淔,鈥� which denotes payment of tax liabilities by retaining/disposing issuer shares rather than a discretionary market sale. The shares were valued at $8.60 each, implying an aggregate value of roughly $19 k for tax settlement purposes.
Following the withholding, Chakravarthy鈥檚 beneficial ownership stands at 438,951 common shares, of which 358,363 are still issuable upon settlement of unvested RSUs. Ownership is shown as direct. The filing contains no purchases, open-market sales, option exercises, or 10b5-1 plan indications, and therefore does not signal a change in investment sentiment. It is a routine administrative transaction that does not alter the executive鈥檚 net economic exposure to ENVX in a meaningful way.
Enovix Corporation (ENVX) 鈥� Form 4 Insider Transaction: President & CEO Rajendra K. Talluri filed a Form 4 reporting an internal share-withholding transaction on 18 June 2025. The filing shows that 17,617 shares of common stock were withheld by the company (transaction code F) to satisfy statutory tax obligations triggered by the same-day vesting of restricted stock units (RSUs). The shares were valued at $8.50 per share, implying a total tax-settlement value of roughly $149,745.
Post-transaction, Talluri鈥檚 beneficial ownership stands at 2,433,335 ENVX shares, of which 1,991,958 shares relate to un-settled RSUs that will convert to common stock upon future vesting. No open-market buying or selling occurred; the transaction is purely administrative and does not change the executive鈥檚 economic exposure in a meaningful way. There were no derivative securities acquired or disposed of beyond the RSU conversion noted above, and no changes in indirect ownership were reported.
The filing is routine and primarily relevant for corporate-governance transparency rather than indicating a directional view on the company鈥檚 prospects. Investors should view the event as neutral: the CEO continues to hold a substantial equity stake, and no liquidity sale was executed.